CHRISTUS Stehlin Foundation for Cancer Research was organized in 1969 as a Texas non-profit corporation. It received original designation from the Internal Revenue Service as a tax-exempt public charity under Internal Revenue Code Section 501 (c)(3) in May 1969 (link to determination letter below).
Though exempt from federal taxation, the Foundation is required to file an information return annually with the Internal Revenue Service. The Foundation’s Forms 990 for recent years are available for viewing and download below. Past year’s returns are available for inspection at the Foundation office.
Form 990 for tax year ending June 30:
The Foundation’s principal purpose and function is to perform medical research. The Internal Revenue Service specifies that donors may deduct contributions to the Foundation from their Federal income taxes as provided in section 170 of the Internal Revenue Code. All bequests, legacies, devises, transfers, or gifts to the Foundation are deductible for Federal estate and gift tax purposes if they meet the applicable provisions of sections 2055, 2106, and 2522 of the Code.
“Compared with other anticancer drugs at similar stages of development, camptothecins have demonstrated a much higher anticancer activity. Camptothecins can be envisioned as the ultimate anticancer drug when fully developed.”
National Academy of Science, 1995